Tong Zhou

Dr. Tong Zhou


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2021 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
JSJunchao Shi
Junchao Shi
YZYunfang Zhang
Yunfang Zhang
DTDongmei Tan
Dongmei Tan
XZXudong Zhang
Xudong Zhang
MYMenghong Yan
Menghong Yan
QCQi Chen
Qi Chen

1 October 2021 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
QCQi Chen
Qi Chen
XZXudong Zhang
Xudong Zhang
JSJunchao Shi
Junchao Shi
MYMenghong Yan
Menghong Yan
TZTong Zhou
Tong Zhou

12 April 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
JSJunchao Shi
Junchao Shi
TZTong Zhou
Tong Zhou
QCQi Chen
Qi Chen

1 November 2020 in Protein & Cell
Verified
Journal Article
Open access
PDF file
GWGuoxia Wen
Guoxia Wen
TZTong Zhou
Tong Zhou
WGWanjun Gu
Wanjun Gu
Circular RNA (circRNA) is a novel class of single-stranded RNAs with a closed loop structure. The majority of circRNAs are formed by a back-splicing process in pre-mRNA splicing. Their expression is dynamically regulated and shows spatiotemporal patterns among cell types, tissues and developmental stages. CircRNAs have important biological functions in many physiological processes, and their aberrant expression is implicated in many human diseases. Due to their high stability, circRNAs are becoming promising biomarkers in many human diseases, such as cardiovascular diseases, autoimmune diseases and human cancers. In this review, we focus on the translational potential of using human blood circRNAs as liquid biopsy biomarkers for human diseases. We highlight their abundant expression, essential biological functions and significant correlations to human diseases in various components of peripheral blood, including whole blood, blood cells and extracellular vesicles. In addition, we summarize the current knowledge of blood circRNA biomarkers for disease diagnosis or prognosis.

1 April 2018 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
JSJunchao Shi
Junchao Shi
EKEun-A Ko
Eun-A Ko
KSKenton M. Sanders
Kenton M. Sanders
QCQi Chen
Qi Chen
TZTong Zhou
Tong Zhou
High-throughput RNA-seq has revolutionized the process of small RNA (sRNA) discovery, leading to a rapid expansion of sRNA categories. In addition to the previously well-characterized sRNAs such as microRNAs (miRNAs), piwi-interacting RNAs (piRNAs), and small nucleolar RNA (snoRNAs), recent emerging studies have spotlighted on tRNA-derived sRNAs (tsRNAs) and rRNA-derived sRNAs (rsRNAs) as new categories of sRNAs that bear versatile functions. Since existing software and pipelines for sRNA annotation are mostly focused on analyzing miRNAs or piRNAs, here we developed the sRNA annotation pipeline optimized for rRNA- and tRNA-derived sRNAs (SPORTS1.0). SPORTS1.0 is optimized for analyzing tsRNAs and rsRNAs from sRNA-seq data, in addition to its capacity to annotate canonical sRNAs such as miRNAs and piRNAs. Moreover, SPORTS1.0 can predict potential RNA modification sites based on nucleotide mismatches within sRNAs. SPORTS1.0 is precompiled to annotate sRNAs for a wide range of 68 species across bacteria, yeast, plant, and animal kingdoms, while additional species for analyses could be readily expanded upon end users’ input. For demonstration, by analyzing sRNA datasets using SPORTS1.0, we reveal that distinct signatures are present in tsRNAs and rsRNAs from different mouse cell types. We also find that compared to other sRNA species, tsRNAs bear the highest mismatch rate, which is consistent with their highly modified nature. SPORTS1.0 is an open-source software and can be publically accessed at https://github.com/junchaoshi/sports1.0.

1 March 2019 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
JSJunchao Shi
Junchao Shi
YZYunfang Zhang
Yunfang Zhang
TZTong Zhou
Tong Zhou
QCQi Chen
Qi Chen